Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?

Table 3 Body mass index, hemoglobin A1c, fasting blood sugar, matrix metalloproteinas-2, -7, and -9 levels at baseline, 3 mo, 12 mo, and 24 mo after sleeve gastrectomy

	BMI (kg/m2)		Waist circumference (cm)		HbA1c (%)		FBS (mg/dL)		MMP-2 (pg/mL)		MMP-7 (pg/mL)		MMP-9 (pg/mL)
	mean	SD	mean	SD	mean	SD	mean	SD	mean	SD	mean	SD	mean	SD
M0	36.2	5.1	109.4	10.5	7.9	1.7	138.3	55.6	15.4	10.8	2.3	1.3	12.1	9.4
M3	30.6	4.6	92.5	9.9	5.9	0.5	91.0	2.2	16.3	12.9	2.1	1.2	16.4	12.2
M12	26.8	4.4	87.1	12.7	5.7	0.5	90.6	3.5	14.4	10.9	2.3	1.2	12.3	7.6
M24	26.9	4.7	87.7	11.3	5.8	0.6	95.1	3.1	27.0	12.0	1.6	1.4	12.1	8.3
P	< 0.0011		< 0.0011		< 0.0011		< 0.0011		0.083		0.869		0.100

¹Statistically significant. SD: Standard deviation; BMI: Body mass index; HbA1c: Hemoglobin A1c; FBS: Fasting blood sugar; MMP: Matrix metalloproteinases; M0: The baseline prior to surgery; M3: 3 mo postoperatively; M12: 12 mo postoperatively; M24: 24 mo postoperatively.